These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26752065)

  • 1. Burden of four vaccine preventable diseases in older adults.
    Kristensen M; van Lier A; Eilers R; McDonald SA; Opstelten W; van der Maas N; van der Hoek W; Kretzschmar ME; Nielen MM; de Melker HE
    Vaccine; 2016 Feb; 34(7):942-9. PubMed ID: 26752065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013.
    McLaughlin JM; McGinnis JJ; Tan L; Mercatante A; Fortuna J
    J Prim Prev; 2015 Aug; 36(4):259-73. PubMed ID: 26032932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older.
    Lehmann BA; Eilers R; Mollema L; Ferreira J; de Melker HE
    BMC Geriatr; 2017 Jun; 17(1):122. PubMed ID: 28592229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness to get vaccinated against influenza, pneumococcal disease, pertussis, and herpes zoster - A pre-COVID-19 exploration among the older adult population.
    Maertzdorf KM; Rietman ML; Lambooij MS; Verschuren WMM; Picavet HSJ
    Vaccine; 2023 Feb; 41(6):1254-1264. PubMed ID: 36639273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of illness of the vaccine-preventable diseases influenza, herpes zoster and pneumococcal disease in France.
    Brown L; Sutton KJ; Browne C; Bartelt-Hofer J; Greiner W; Petitjean A; Roiz J
    Eur J Public Health; 2024 Feb; 34(1):170-175. PubMed ID: 38061039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain.
    Pérez-Rubio A; Mestre-Ferrandiz J; López-Belmonte JL; Diaz-Aguiló A; Lorenzo-Herrero S; Crespo C
    BMC Infect Dis; 2024 Aug; 24(1):779. PubMed ID: 39103777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011.
    van Lier A; McDonald SA; Bouwknegt M; ; Kretzschmar ME; Havelaar AH; Mangen MJ; Wallinga J; de Melker HE
    PLoS One; 2016; 11(4):e0153106. PubMed ID: 27097024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine preferences and acceptance of older adults.
    Eilers R; de Melker HE; Veldwijk J; Krabbe PFM
    Vaccine; 2017 May; 35(21):2823-2830. PubMed ID: 28412075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium.
    Bilcke J; Marais C; Ogunjimi B; Willem L; Hens N; Beutels P
    Vaccine; 2012 Jan; 30(3):675-84. PubMed ID: 22120193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
    Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
    Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands.
    van Lier A; de Gier B; McDonald SA; Mangen MJ; van Wijhe M; Sanders EAM; Kretzschmar ME; van Vliet H; de Melker HE
    Euro Surveill; 2019 May; 24(18):. PubMed ID: 31064637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.
    Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Bridges CB;
    MMWR Surveill Summ; 2016 Feb; 65(1):1-36. PubMed ID: 26844596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of vaccine candidates for persons aged 50 and older: a review.
    Eilers R; Krabbe PF; van Essen TG; Suijkerbuijk A; van Lier A; de Melker HE
    BMC Geriatr; 2013 Apr; 13():32. PubMed ID: 23586926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands.
    McDonald SA; van Lier A; Plass D; Kretzschmar ME
    BMC Public Health; 2012 Dec; 12():1046. PubMed ID: 23217094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of influenza, pneumococcal and herpes zoster vaccination coverage in Australian aged care residents, 2018 to 2022.
    Bennett N; Morris B; Malloy MJ; Lim LL; Watson E; Bull A; Sluggett J; Worth LJ;
    Infect Dis Health; 2023 Nov; 28(4):253-258. PubMed ID: 37147271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The public health value of vaccination for seniors in Europe.
    Esposito S; Franco E; Gavazzi G; de Miguel AG; Hardt R; Kassianos G; Bertrand I; Levant MC; Soubeyrand B; López Trigo JA
    Vaccine; 2018 May; 36(19):2523-2528. PubMed ID: 29615269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013.
    Cassini A; Colzani E; Pini A; Mangen MJ; Plass D; McDonald SA; Maringhini G; van Lier A; Haagsma JA; Havelaar AH; Kramarz P; Kretzschmar ME;
    Euro Surveill; 2018 Apr; 23(16):. PubMed ID: 29692315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.
    de Boer PT; Pouwels KB; Cox JM; Hak E; Wilschut JC; Postma MJ
    Vaccine; 2013 Feb; 31(9):1276-83. PubMed ID: 23306360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
    Tseng HF; Smith N; Sy LS; Jacobsen SJ
    Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.